Press Release Stockholm, Sweden, December 11, 2021 Immunicum Presents Phase II Data Demonstrating Reduced MRD and Improved Survival with DCP-001...
Phase 1 study demonstrated pharmacokinetics (PK) equivalence and comparable pharmacodynamic (PD), safety, immunogenicity profiles between SB12 and reference eculizumabINCHEON, Korea,...
Figure 1 Refractory Patients’ Serum IgM Levels After Treatment with Mavorixafor + Ibrutinib vs. Ibrutinib Monotherapy With or Without CXCR4...
Encouraging clinical activity in higher dose cohorts with 63% ORR and 88% DCR reported in 2150 µg/week cohort with 8...
Results to be presented for the first time show mosunetuzumab induces high and durable complete response rates in people with...
NEWS RELEASE – REGULATED INFORMATION 10 December 2021, 23:55 CET MDxHealth Shareholder Transparency Declaration IRVINE, CA, and HERSTAL, BELGIUM –...
EDGEWATER, N.J., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Joseph Frontiere, CEO of Quad M Solutions, Inc. said “Quad M Solutions...
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early...
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world’s largest provider of hair testing for drugs...
Boards have made small advances in diversity; less time is spent on strategic planningLINCOLN, Neb., Dec. 10, 2021 (GLOBE NEWSWIRE)...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November...
MENLO PARK, Calif. and BOSTON, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
VANCOUVER, Washington, Dec. 10, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
EDGEWATER, N.J., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Joseph Frontiere, CEO of Quad M Solutions, Inc. said “Quad M Solutions...
New York, NY, and Tel Aviv, ISRAEL, Dec. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a...
Monthly information related to total number of voting rights and shares composing...
KANSAS CITY, Kan., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cingulate Inc. (“Cingulate” or the “Company”), a clinical-stage biopharmaceutical company utilizing...
BOSTON, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
$TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS Cambridge Orthopaedic Labs Ltd $TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS Cambridge Orthopaedic...
6th indication for toripalimab submitted in ChinaSHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877; SSE: 688180),...
